1)James R, Butler JR, Ahmad SA, et al:A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma. HPB 18:305-311, 2016
2)Tummers WS, Groen JV, Mulder BGS, et al:Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. BJS 106:1055-1065, 2019
3)Ghaneh P, Kleeff J, MD Halloran CM, et al:The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Ann Surg 269:520-529, 2019
4)日本膵臓学会(編):膵癌取扱い規約.2016年7月 第7版.金原出版,2016
5)Brierley JD, Gospodarowicz MK, Wittekind C:UICC:TNM Classification of Malignant Tumours, 8th ed. Oxford, England, Wiley-Blackwell, 2017
6)The guidelines of the British Royal College of Pathology〔https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-.html〕
7)Liu L, Katz MH, Lee SM, et al:Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol 39:1395-1403, 2015
8)Hank T, Hinz U, Tarantino I, et al:Validation of at least 1mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. BJS 105:1171-1181, 2018
1)Campbell FFA, Verbeke CS:The Guideline of the Royal College of Pathologists. Standards and minimum datasets for reporting cancers:dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. The royal college of Pathologists, 2010
2)Brierley JD, Gospodarowicz MK, Wittekind C(ed):UICC:TNM Classification of Malignant Tumors, 8th ed. Oxford, Wiley-Blackwell, 2017
3)Amin MB, Greene FL, Edge SB, et al:AJCC Cancer Staging Manual. 8th ed. New York, Springer, 2016
4)Verbeke CS, Leitch D, Menon KV, et al:Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232-1237, 2006
5)Raut CP, Tseng JF, Sun CC, et al:Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52-60, 2007
6)Campbell F, Smith RA, Whelan P, et al:Classification of R1 resections for pancreatic cancer:the prognostic relevance of tumour involvement within 1mm of a resection margin. Histopathology 55:277-283, 2009
7)Chang DK, Johns AL, Merrett ND, et al:Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 27:2855-2862, 2009
8)Menon KV, Gomez D, Smith AM, et al:Impact of margin status on survival following pancreatoduodenectomy for cancer:the Leeds Pathology Protocol(LEEPP). HPB 11:18-24, 2009
9)Gaedcke J, Gunawan B, Grade M, et al:The mesopancreas is the primary site for R1 resection in pancreatic head cancer:relevance for clinical trials. Langenbecks Arch Surg 395:451-458, 2010
10)Hartwig W, Hackert T, Hinz U, et al:Pancreatic cancer surgery in the new millennium:better prediction of outcome. Ann Surg 254:311-319, 2011
11)Cannon RM, LeGrand R, Chagpar RB, et al:Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB 14:228-235, 2012
12)Rau BM, Moritz K, Schuschan S, et al:R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152(Suppl 1):S103-111, 2012
13)Jamieson NB, Chan NI, Foulis AK, et al:The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg 17:511-521, 2013
14)Janot MS, Kersting S, Belyaev O, et al:Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head? Langenbecks Arch Surg 397:917-925, 2012
15)John BJ, Naik P, Ironside A, et al:Redefining the R1 resection for pancreatic ductal adenocarcinoma:tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival. HPB 15:674-680, 2013
16)Konstantinidis IT, Warshaw AL, Allen JN, et al:Pancreatic ductal adenocarcinoma:is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257:731-736, 2013
17)Maksymov V, Hogan M, Khalifa MA:An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment. HPB 15:218-223, 2013
18)Sugiura T, Uesaka K, Mihara K, et al:Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery 154:1078-1086, 2013
19)Delpero JR, Bachellier P, Regenet N, et al:Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma:a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB 16:20-33, 2014
20)Elebro J, Jirstrom K:Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma. Diagn Pathol 9:80, 2014
21)Kooby DA, Lad NL, Squires MH 3rd, et al:Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma:a multicenter analysis of 1399 patients. Ann Surg 260:494-501;discussion -3, 2014
22)Gebauer F, Tachezy M, Vashist YK, et al:Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol(LEEPP):clinically relevant or just academic? World J Surg 39:493-499, 2015
23)Delpero JR, Jeune F, Bachellier P, et al:Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma:Updates From a French Prospective Multicenter Study. Ann Surg 266:787-796, 2017
24)Nitta T, Nakamura T, Mitsuhashi T, et al:The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Surg Today 47:490-497, 2017
25)Strobel O, Hank T, Hinz U, et al:Pancreatic Cancer Surgery:The New R-status Counts. Ann Surg 265:565-573, 2017
26)Hank T, Hinz U, Tarantino I, et al:Validation of at least 1mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. Br J Surg 105:1171-1181, 2018
27)Demir IE, Jager C, Schlitter AM, et al:R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer. Ann Surg 268:1058-1068, 2018
28)Ghaneh P, Kleeff J, Halloran CM, et al:The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Ann Surg 269:520-529, 2019
29)Tummers WS, Groen JV, Sibinga Mulder BG, et al:Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg 106:1055-1065, 2019
30)Yamamoto T, Uchida Y, Terajima H:Clinical impact of margin status on survival and recurrence pattern after curative-intent surgery for pancreatic cancer. Asian J Surg 42:93-99, 2019
31)Butturini G, Stocken DD, Wente MN, et al:Influence of resection margins and treatment on survival in patients with pancreatic cancer:meta-analysis of randomized controlled trials. Arch Surg(Chicago, Ill :1960)143:75-83;discussion, 2008
32)Chandrasegaram MD, Goldstein D, Simes J, et al:Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg 102:1459-1472, 2015
33)Kim KS, Kwon J, Kim K, et al:Impact of Resection Margin Distance on Survival of Pancreatic Cancer:A Systematic Review and Meta-Analysis. Cancer Res Treat 49:824-833, 2017
34)Andriulli A, Festa V, Botteri E, et al:Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer:a meta-analysis of prospective studies. Ann Surg Oncol 19:1644-1662, 2012
35)de Geus SWL, Kasumova GG, Sachs TE, et al:Neoadjuvant therapy affects margins and margins affect all:perioperative and survival outcomes in resected pancreatic adenocarcinoma. HPB 20:573-581, 2018
36)Liu DN, Lv A, Tian ZH, et al:Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma. Oncotarget 8:7766-7776, 2017